全球智库信息集成服务系统

Evidence for Using Mindfulness-Based Cognitive Therapy to Treat MDD Is Limited

• The evidence supports the use of adjunctive MBCT to reduce depressive symptoms among those currently depressed. The evidence also supports the use of adjunctive MBCT to reduce relapse among those with a history of at least three previous depressive episodes.
• Evidence on the use of monotherapy MBCT is insufficient to draw conclusions about its efficacy, either to reduce depressive symptoms among those currently depressed or among those with a history of depression to reduce relapse.
• There is insufficient evidence on the effect of MBCT on health-related quality of life. Few studies examined the effect of MBCT on measures of health-related quality of life, and there was a lack of consistency in comparators used and the measures of health-related quality of life included.
• The evidence suggests that adjunctive MBCT does not significantly affect antidepressant use.
• The reported occurrence of adverse events was infrequent and did not appear to be related to MBCT. Only six of the included studies reported on adverse events.